Ask AI

Key Updates in the Treatment of HER2-Positive Breast Cancer

Gain expert insights on current and emerging HER2-targeted therapies for patients with HER2-positive metastatic breast cancer including best practice for managing treatment-related adverse events.

Share

Program Content

Activities

Key Updates in HER2+ MBC
Key Updates in the Treatment of HER2-Positive Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 11, 2020

Expires: May 10, 2021

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Seagen